Acne Serum Maker Cleans Up 100% Gains

A tobacco giant’s smoke-free shift is lifting its earnings, a telecom major is dialing in steady subscriber growth and strong broadband gains, and a healthcare microcap is surging 100%+ after a major UK retail launch. Here’s what’s moving the markets today.

Energy Sector Watch (Sponsored)

On Behalf of Azincourt Energy Corp

The Next Big Name in Uranium?

The uranium bull market is heating up.

Uranium has doubled since 2020.

Saskatchewan’s uranium sales just hit $2.6 billion, up 62% year-over-year.

Cameco says the long-term outlook has never been stronger.

Now layer on the global demand curve:

The setup is here.

And one company has plans to drill in the heart of it all: Canada’s Athabasca Basin.

With early uranium hits, expanding alteration zones, and proximity to NexGen and Cameco, this could be the next name to watch in the sector.

Discover the full story behind this quietly rising stock.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Futures 📈

What to Watch

Earnings:

Economic Reports:

AI & Machine Learning (Sponsored)

10 AI Stocks Quietly Powering the Next Tech Boom

The headlines may be focused on the usual suspects—Nvidia, OpenAI, Microsoft—but the biggest AI gains of 2025 may come from lesser-known players quietly shaping the future.

While the world races to adopt automation, machine learning, and AI-driven solutions, a new group of innovators is building the foundation.

(By clicking any of the links above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy.)

These companies aren’t just riding the AI trend—they’re developing the infrastructure, software, and services behind it.

A new report reveals 10 AI stocks that are flying under the radar… for now. These companies are already securing deals across healthcare, energy, logistics, and finance.

If you missed the first wave of AI gains, this may be your second chance.

Click here to unlock the full list—free for a limited time.

(By clicking any of the links above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy.)

Tobacco

Philip Morris Lifts Outlook as Smoke-Free Sales Drive Q1 Beat

Philip Morris International (NYSE: PM) reported strong first-quarter 2025 results today morning, driven by impressive growth in its smoke-free product portfolio and continued gains across key international markets.

The company posted diluted earnings per share of $1.72, marking a 24.6% increase from the same period last year.

Adjusted EPS is up 12.7% to $1.69, and 17.3% excluding currency impacts.

You might like: Time-sensitive trades? Get instant AI alerts before the market moves. (ad)

Net revenue is at $9.3 billion, up by 5.8%, and organic revenue is up by 10.2%. Gross profit climbed 11.8% to $6.3 billion, with organic growth hitting 16%.

Smoke-free products account for 42% of PMI’s total revenue and 44% of gross profit, as demand for IQOS devices continued to grow, particularly in Japan and Europe.

Shipment volumes of smoke-free products rose 14.4%, while e-vapor volumes more than doubled, led by strength in Europe. In the U.S., ZYN nicotine pouches boosted oral smoke-free volumes by 27.2%.

CEO Jacek Olczak expressed confidence in PMI’s transition toward a smoke-free future and highlighted organic growth in smoke-free net revenue and profit—up over 20% and 33%, respectively.

PMI also raised its full-year adjusted EPS forecast to a range of $7.01 to $7.14, representing a projected increase of 10.5% to 12.5% on an organic basis.

The company reaffirmed its dividend of $1.35 per share and confirmed it will retain its U.S. cigar business following a strategic review.

Telecom

AT&T Tops Revenue Forecast, Reaffirms Full-Year Guidance

AT&T (NYSE: T) shares are up nearly 4% in premarket trading Wednesday after delivering first-quarter results that surpassed Wall Street expectations for both revenue and subscriber growth.

The company reported adjusted earnings per share of $0.51 on revenue of $30.63 billion, marking a 2% year-over-year increase.

While the EPS slightly missed the $0.52 consensus estimate, revenue exceeded projections of $30.34 billion.

Don’t miss: Retirement savings at risk? This free guide shows how to protect them now. (ad)

AT&T added 324,000 net postpaid phone subscribers, outpacing the anticipated 252,800.

It also signed up 261,000 new AT&T Fiber internet customers—just below the 264,300 forecasted by analysts.

These numbers underscore continued strength in both its wireless and broadband segments despite a highly competitive market.

CEO John Stankey reiterated confidence in the company’s 2025 strategy, stating that its core business remains resilient and aligned with its long-term financial roadmap.

AT&T maintained its full-year guidance, which includes low single-digit service revenue growth, at least 3% adjusted EBITDA growth, and adjusted EPS in the range of $1.97 to $2.07.

With solid customer additions and stable financials, AT&T appears well-positioned to navigate ongoing market challenges and sustain momentum through the rest of the year.

AI-Powered Aviation (Sponsored)

Aviation’s Next Big Disruptor Could Be Here

If you're searching for the next opportunity, this aviation player is quietly making moves in the industry.

No guarantees, but when the right elements come together, we’ve seen how momentum can take off for other companies before.

The Timing is Everything.

One of the biggest game-changers? A strategic agreement with Palantir Technologies(1) to develop an AI-driven operating system designed to revolutionize the advanced air mobility industry.

Aviation has been slow to embrace AI, but this company is working on real, data-driven software that could revolutionize regional air travel.

Aviation is next, and this company is positioning itself ahead of the curve.

Insiders Are Betting on It.

Board members have increased their holdings.

Analysts across multiple platforms are calling this a company to watch

Appreciate you tuning in—potential disruptors like this don’t come around often.

Stay sharp, stay informed, and take the next step to uncover the full details.

Unlock the name and symbol now right here.

*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.

Drug Development

Thermo Fisher Surges on Q1 Beat and $4.1B Deal with Solventum

Thermo Fisher Scientific (NYSE: TMO) shares are up 3.5% in premarket trading today after the company reported first-quarter results that outperformed analyst estimates and announced a major acquisition.

For the quarter ended March 29, the life sciences giant delivered adjusted earnings per share of $5.15, edging past the expected $5.11.

Revenue totaled $10.36 billion, slightly ahead of the $10.23 billion forecast and just above the $10.34 billion recorded in the same quarter a year ago.

Trending now: A strange pattern just appeared in the crypto markets—only seen 3 times before. (ad)

Organic revenue rose 1% year-over-year, while GAAP diluted EPS jumped 15% to $3.98. Adjusted EPS also ticked up 1% compared to one year ago.

In a strategic move to expand its capabilities, Thermo Fisher revealed it has agreed to acquire Solventum’s Purification & Filtration Business for $4.1 billion in cash.

The acquisition is expected to strengthen Thermo Fisher’s presence in the bioproduction space.

Additionally, the company returned capital to shareholders with a $2 billion stock buyback and a 10% dividend increase during the quarter—signals of strong cash flow and confidence in future performance.

With both financial metrics and M&A activity reinforcing growth momentum, Thermo Fisher remains firmly positioned as a key player in the healthcare and scientific instrumentation market heading into the remainder of 2025.

Sonoma Pharmaceuticals, Inc. [SNOA] - Last Close: $2.33

​Sonoma Pharmaceuticals is a global healthcare company.

Its stock is surging 118% in premarket trading after announcing that its HOCl-based acne products, including a toner and balancing serum, will be sold through a prominent UK pharmacy chain with over 1,200 stores.

Pegasystems Inc. [PEGA] - Last Close: $67.86

Pegasystems Inc. is a leader in AI-powered workflow automation and customer engagement software. Its shares are soaring 27%+ in premarket trading after the company reported Q1 2025 results that significantly exceeded expectations.

Adjusted earnings per share came in at $1.53, beating the consensus estimate of $0.49, while revenue rose 44% year-over-year to $475.63 million, surpassing forecasts of $356.6 million.

Vertiv Holdings, LLC [VRT] - Last Close: $71.82

Vertiv Holdings specializes in power, cooling, and IT management solutions for data centers and edge computing. Shares of Vertiv are up 18% in premarket trading after it posted strong Q1 earnings.

Adjusted EPS came in at $0.64, beating the $0.61 estimate, while revenue climbed 24% year-over-year to $2.04 billion—well above the $1.94 billion forecast.

Clean Energy (Sponsored)

Could Nuclear Energy Be the Market’s Dark Horse in 2025?

The world is waking up to a hard truth: clean energy can’t scale without nuclear.

From the U.S. to the EU to Asia, leaders are throwing their weight behind next-gen nuclear power—fast-tracking approvals, funding advanced reactors, and locking in uranium supply for decades.

(By clicking any of the links above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy.)

A newly released report reveals 7 nuclear stocks with exposure to this energy renaissance. From uranium producers to nuclear tech firms, these names are flying under the radar… for now.

But with rising energy demand and global policy tailwinds, that won’t last long.

[Click here to see all 7 tickers now.]

(By clicking any of the links above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy.)

Everything Else

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club